utility

header_second

RegMed Investors (RMi) went exclusive on July 27th!

Your complimentary subscription to RegMed Investors’ (RMi) reporting on the stem, cell and gene therapy and RegMed sector has expired.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.

It’s up to you to choose the level of content access to provide a premium experience and value - don’t wait to exhale!

I also bring fresh perspectives that yield a whole that is greater than the sum of the parts as I convey a spectrum of factors that explain outcomes, analytical principles and analysis without the encumbrance of trading, investment or I-Banking.

So, after these years of following our facts … first and fast; be part of our “inner circle” as a subscriber!

Stay with me and join our coalition and have a seat at the appreciation table!

Login Sign up now Not now

content_top

34 companies, 1 interpreter! Insight, foresight
and recommendation

Closing Bell

content_middle

Closing Bell

content_right

March 13, 2026 - 5:14pm | Closing Bell
RMi Closing Bell: Sentiment was conceded

CAPR, CAPR, CAPR, OTCQB: HRGN< IBB, NBI, RUT, NBI, IWM, XBI, VIX
March 12, 2026 - 4:55pm | Closing Bell
RMi Closing Bell: Wipe-out, econs and oil drop the sector… again

CAPR, OTCQB: HRGN, AXGN, - MiMedx (MDXG), Ultragenyx (RARE), Editas Medicine (EDIT)
March 11, 2026 - 4:54pm | Closing Bell
RMi Closing Bell: Econ ordered; then delivered the whys

CAPR, OTCQB: HRGN, SLDB, RGNX
March 10, 2026 - 4:38pm | Closing Bell
RMi Closing Bell: The share pricing tug-a-war, literally

CAPR, CAPR, CAPR, OTCQB: HRGN< IBB, NBI, RUT, NBI, IWM, XBI, VIX
March 9, 2026 - 4:55pm | Closing Bell
RMi Closing Bell: Slam, bam in a manic Monday

CAPR, OTCQB: HRGN
March 8, 2026 - 3:18pm | Closing Bell
RMi Closing Bell: What happened Friday, more declines as econ added to the negative mood

CAPR, OTCQB: HRGN
March 5, 2026 - 4:46pm | Closing Bell
RMi Closing Bell: Which direction and what is the wind blowing?
March 4, 2026 - 7:52pm | Closing Bell
RMi Closing Bell: Stay frosty

CAPR, CAPR, OTCQB: HRGN< IBB, NBI, RUT, NBI, IWM, XBI, VIX
March 3, 2026 - 5:00pm | Closing Bell
RMi Closing Bell: Spoiling the risk appetite

CAPR, CAPR, CAPR, CAPR, OTCQB: HRGN< IBB, NBI, RUT, NBI, IWM, XBI, VIX
March 2, 2026 - 4:42pm | Closing Bell
RMi Closing Bell: Recovery

CAPR, CAPR, CAPR, OTCQB: HRGN< IBB, NBI, RUT, NBI, IWM, XBI, VIX
February 27, 2026 - 4:57pm | Closing Bell
RMi Closing Bell: Econs crush indexes and share pricings

CAPR, CAPR, CAPR, OTCQB: HRGN< IBB, NBI, RUT, NBI, IWM, XBI, VIX
February 26, 2026 - 4:53pm | Closing Bell
RMi Closing Bell: Luck was a happening

CAPR, OTCQB: HRGN
February 25, 2026 - 4:48pm | Closing Bell
RMi Closing Bell: Still standing in the ring yet bloodied

CAPR, OTCQB: HRGN
February 24, 2026 - 4:49pm | Closing Bell
RMi Closing Bell: Cell and gene therapy sector bounds

CAPR, OTCQB: HRGN
February 23, 2026 - 5:06pm | Closing Bell
RMi Closing Bell: Snow shoeing through Ai and cell and gene therapy sector blizzard

CAPR, OTCQB: HRGN
February 20, 2026 - 4:44pm | Closing Bell
RMi Closing Bell: A risk clearing session with semi-healthy econ reports

CAPR, OTCQB: HRGN, CAPR, OTCQB: HRGN, OTCQB: BCLI
February 19, 2026 - 4:48pm | Closing Bell
RMi Closing Bell: Rotational volatility

CAPR, CAPR, CAPR, OTCQB: HRGN< IBB, NBI, RUT, NBI, IWM, XBI, VIX
February 18, 2026 - 5:05pm | Closing Bell
RMi Closing Bell: Boom

CAPR, CAPR, CAPR, OTCQB: HRGN< IBB, NBI, RUT, NBI, IWM, XBI, VIX
February 17, 2026 - 4:46pm | Closing Bell
RMi Closing Bell: Sector share pricing on a tear

OTCQB: HRGN, CAPR, CAPR, OTCQB: HRGN< IBB, NBI, RUT, NBI, IWM, XBI, VIX
February 13, 2026 - 5:03pm | Closing Bell
RMi Closing Bell: Relief

CAPR, CAPR, CAPR, OTCQB: HRGN< IBB, NBI, RUT, NBI, IWM, XBI, VIX

Pages

footer

© 2015 RegMed Investors (regmedinvestors.com), all rights are reserved.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry MCusker . Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of RegMed Investors (RM-i); who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other RM-i media services or reposting please email hwm@regmedinvestors.com.